Who owns NEUMORA THERAPEUTICS INC.?
- Ticker: NMRA
- CUSIP Number: 640979100
Tip: Access positions for across all investors
Analyze quarterly positions in Neumora Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neumora Therapeutics stock
Who bought or sold NEUMORA THERAPEUTICS INC. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Softbank Group Corp | 6.4M | $12M | -2% | Dec 2025 |
|
| Siren | 6.3M | $11M | 44% | Dec 2025 |
|
| Perceptive Advisors | 5.1M | $10M | 100% | Mar 2026 |
|
| Vanguard Group | 4.5M | $8.1M | 12% | Dec 2025 |
|
| MIC Capital Management UK | 4.5M | $8.7M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 3.9M | $7.6M | 100% | Mar 2026 |
|
| FMR | 3.5M | $6.3M | 0% | Dec 2025 |
|
| Wellcome Trust Limited, as Trustee of the Wellcome Trust | 3.3M | $6.5M | 0% | Mar 2026 |
|
| Millennium Management | 2.8M | $5.4M | -24% | Mar 2026 |
|
| ICONIQ Capital | 2.6M | $4.6M | 0% | Dec 2025 |
|
| Lunate Capital | 2.1M | $4.1M | 0% | Mar 2026 |
|
| BlackRock | 2.1M | $4.0M | 1% | Mar 2026 |
|
| Two Sigma Investments | 2.0M | $4.0M | 56% | Mar 2026 |
|
| Johnson & Johnson | 1.8M | $3.6M | 0% | Mar 2026 |
|
| Renaissance Technologies | 1.4M | $2.6M | 24% | Dec 2025 |
|
| Tudor Investment Corporation | 1.3M | $2.6M | 100% | Mar 2026 |
|
| Ikarian Capital | 1.3M | $2.5M | 0% | Mar 2026 |
|
| Geode Capital Management | 1.1M | $2.1M | 8% | Mar 2026 |
|
| Susquehanna International | 799k | $1.4M | 68% | Dec 2025 |
|
| Jane Street | 748k | $1.5M | -35% | Mar 2026 |
|
| AlphaCore Capital | 639k | $1.2M | 0% | Mar 2026 |
|
| Point72 Asset Management | 602k | $1.2M | -84% | Mar 2026 |
|
| Marshall Wace | 584k | $1.0M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 568k | $1.1M | -34% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 535k | $1.0M | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 513k | $917k | 0% | Dec 2025 |
|
| Franklin Resources | 511k | $997k | 100% | Mar 2026 |
|
| Morgan Stanley | 504k | $982k | 111% | Mar 2026 |
|
| Tang Capital Management | 440k | $858k | -55% | Mar 2026 |
|
| Citadel Advisors | 421k | $821k | -24% | Mar 2026 |
|
| State Street Corporation | 389k | $696k | 0% | Dec 2025 |
|
| Acadian Asset Management | 382k | $738k | 59% | Mar 2026 |
|
| Dimensional Fund Advisors | 355k | $692k | 231% | Mar 2026 |
|
| Boothbay Fund Management | 335k | $654k | 0% | Mar 2026 |
|
| Federated Investors | 314k | $613k | 0% | Mar 2026 |
|
| Jacobs Levy Equity Management | 274k | $534k | -42% | Mar 2026 |
|
| HPM Partners | 260k | $508k | -5% | Mar 2026 |
|
| Bridgeway Capital Management | 225k | $403k | 0% | Dec 2025 |
|
| GSA Capital Partners | 218k | $425k | -59% | Mar 2026 |
|
| Invesco | 206k | $402k | -10% | Mar 2026 |
|
| Hrt Financial | 199k | $387k | 100% | Mar 2026 |
|
| Northern Trust | 185k | $332k | 17% | Dec 2025 |
|
| Vanguard Portfolio Management | 185k | $360k | 100% | Mar 2026 |
|
| Bank of America Corporation | 177k | $345k | 100% | Mar 2026 |
|
| Addis & Hill | 163k | $319k | 0% | Mar 2026 |
|
| Squarepoint Ops | 156k | $305k | -16% | Mar 2026 |
|
| SkyOak Wealt | 150k | $293k | 50% | Mar 2026 |
|
| EntryPoint Capital | 145k | $260k | 100% | Dec 2025 |
|
| Canada Pension Plan Investment Board | 140k | $273k | 53% | Mar 2026 |
|
| XTX Topco | 114k | $204k | 100% | Dec 2025 |
|
| Meridian Wealth Management | 102k | $200k | 19% | Mar 2026 |
|
| Virtu Financial | 97k | $174k | 466% | Dec 2025 |
|
| Brevan Howard Capital Management | 97k | $189k | 100% | Mar 2026 |
|
| Voleon Capital Management | 94k | $183k | 200% | Mar 2026 |
|
| Rbf Capital | 90k | $176k | -14% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 77k | $150k | 0% | Mar 2026 |
|
| Susquehanna Portfolio Strategies | 72k | $129k | 75% | Dec 2025 |
|
| DAFNA Capital Management | 70k | $137k | 100% | Mar 2026 |
|
| JustInvest | 62k | $121k | -4% | Mar 2026 |
|
| UBS Group | 60k | $116k | -37% | Mar 2026 |
|
| Balyasny Asset Management | 58k | $112k | 100% | Mar 2026 |
|
| AQR Capital Management | 56k | $109k | -41% | Mar 2026 |
|
| OMERS Administration Corporation | 51k | $99k | -63% | Mar 2026 |
|
| Citigroup | 49k | $95k | 100% | Mar 2026 |
|
| Group One Trading | 46k | $90k | 100% | Mar 2026 |
|
| Amg National Trust Bank | 43k | $85k | 0% | Mar 2026 |
|
| Bank of New York Mellon | 39k | $76k | 0% | Mar 2026 |
|
| American Century Companies | 39k | $70k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 34k | $65k | 171% | Mar 2026 |
|
| Catalyst Funds Management Pty | 33k | $65k | 12% | Mar 2026 |
|
| Sig Brokerage | 33k | $59k | -6% | Dec 2025 |
|
| ADAR1 Capital Management | 33k | $65k | -35% | Mar 2026 |
|
| Leucadia National Corporation | 33k | $64k | -25% | Mar 2026 |
|
| Diametric Capital | 33k | $64k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 31k | $61k | 100% | Mar 2026 |
|
| Barclays | 31k | $55k | 202% | Dec 2025 |
|
| China Universal Asset Management | 30k | $58k | 9% | Mar 2026 |
|
| Legacy Private Trust | 19k | $37k | 0% | Mar 2026 |
|
| Tower Research Capital | 18k | $32k | -16% | Dec 2025 |
|
| SG Americas Securities | 17k | $33k | -74% | Mar 2026 |
|
| HBK Sorce Advisory | 17k | $31k | 0% | Mar 2026 |
|
| Clarius | 17k | $30k | 0% | Dec 2025 |
|
| Arrowpoint Investment Partners | 16k | $31k | 100% | Mar 2026 |
|
| Woodline Partners | 15k | $29k | 0% | Mar 2026 |
|
| Walleye Trading Advisors | 14k | $27k | -35% | Mar 2026 |
|
| Ieq Capital | 13k | $24k | -25% | Dec 2025 |
|
| Hsbc Holdings | 11k | $23k | -24% | Mar 2026 |
|
| Quadrature Capital | 11k | $20k | 100% | Dec 2025 |
|
| Winton Capital | 10k | $20k | 100% | Mar 2026 |
|
| Mirae Asset Global Investments | 8.7k | $17k | 7% | Mar 2026 |
|
| Wells Fargo & Company | 5.5k | $11k | -45% | Mar 2026 |
|
| CWM | 5.2k | $9.0k | -54% | Dec 2025 |
|
| Gf Fund Management | 3.7k | $7.3k | 14% | Mar 2026 |
|
| Rhumbline Advisers | 2.6k | $5.0k | 0% | Mar 2026 |
|
| NISA Investment Advisors | 1.5k | $2.9k | 0% | Mar 2026 |
|
| UMA Financial Services | 1.3k | $2.6k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 1.2k | $2.2k | -42% | Mar 2026 |
|
| Pnc Financial Services | 1.0k | $2.0k | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 298.00 | $596.000000 | -7% | Mar 2026 |
|
| Parallel Advisors | 279.00 | $543.994200 | 0% | Mar 2026 |
|
| Signature | 264.00 | $515.011200 | 100% | Mar 2026 |
|
| Centerpoint Advisors | 220.00 | $0 | 0% | Mar 2026 |
|
| Fortitude Family Office | 167.00 | $326.000700 | -84% | Mar 2026 |
|
| Capital Advisors | 145.00 | $0 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 21.00 | $41.000400 | 320% | Mar 2026 |
|
| SBI Securities | 18.00 | $34.999200 | -5% | Mar 2026 |
|
Who sold out of Neumora Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| T. Rowe Price Investment Management | Sep 2025 | 1.9M | $3.5M |
| Two Sigma Advisers | Dec 2025 | 1.1M | $1.9M |
| Graham Capital Management | Dec 2025 | 191k | $343k |
| ExodusPoint Capital Management | Dec 2025 | 181k | $324k |
| Ohio Pers | Sep 2025 | 24k | $44k |
| Fred Alger Management | Dec 2025 | 22k | $40k |
| Walleye Trading | Dec 2025 | 13k | $23k |
| Engineers Gate Manager | Sep 2025 | 12k | $22k |
| Creative Planning | Dec 2025 | 11k | $20k |
| Jpmorgan Chase & Co | Sep 2025 | 11k | $19k |
| Simplex Trading | Sep 2025 | 8.5k | $15k |
| Optiver Holding B.V. | Dec 2025 | 592.00 | $1.1k |
| Daiwa Securities Group | Dec 2025 | 533.00 | $1.0k |
| Optima Capital | Dec 2025 | 270.00 | $483.003000 |
| Essential Partners | Dec 2025 | 30.00 | $54.000000 |